SEC Form 4 · accession 0001140361-16-047740
Protea Biosciences Group, Inc. · PRGB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Greg Kilby
Officer — Vice President, Operations
Period of report
Dec 18, 2015
Accepted (ET)
Jan 13, 2016 · 4:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001335103
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.25 | Dec 18, 2015 | A | 450,000 | A | Dec 18, 2016 | Dec 18, 2025 | Common Stock | 450,000 | 450,000 | D |
Explanation of responses
- F1The Stock Option vests in 112,500 share increments annually on each of the first four anniversaries of the date of grant beginning on December 18, 2016.